Multiple myeloma: the death of VAD as initial therapy
- 1 July 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (1) , 2-3
- https://doi.org/10.1182/blood-2005-04-1451
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Thalidomide Plus Dexamethasone Versus Dexamethasone Alone in Newly Diagnosed Multiple Myeloma (E1A00): Results of a Phase III Trial Coordinated by the Eastern Cooperative Oncology Group.Blood, 2004
- Multiple MyelomaNew England Journal of Medicine, 2004
- Treatment of Plasma Cell Dyscrasias With Thalidomide and Its DerivativesJournal of Clinical Oncology, 2003
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984